High pre-treatment neutrophil-to-lymphocyte ratio as a prognostic marker for worse survival in patients with recurrent/metastatic cervical cancer treated with immune checkpoint inhibitors

High pre-treatment neutrophil-to-lymphocyte ratio as a prognostic marker for worse survival in patients with recurrent/metastatic cervical cancer treated with immune checkpoint inhibitors

Objective: To evaluate the association between pre-treatment neutrophil-to-lymphocyte ratio (NLR) and survival outcomes among patients with recurrent/metastatic cervical cancer treated with PD-1/PD-L1 inhibitors. Methods: A retrospective analysis of patients with recurrent/metastatic cervical cancer...

Full description

Bibliographic Details
Main Authors: Corinne A. Calo, David A. Barrington, Morgan Brown, Lynette Gonzalez, Jae Baek, Allison Huffman, Jason Benedict, Floor Backes, Laura Chambers, David Cohn, Larry Copeland, Casey Cosgrove, Christa Nagel, David O'Malley, Kristin Bixel
Format: Article
Language:English
Published: Elsevier 2022-08-01
Series:Gynecologic Oncology Reports
Subjects:
Cervical cancer
Neutrophil-to-lymphocyte ratio
Immunotherapy
Checkpoint inhibitors
Prognostic marker
Online Access:http://www.sciencedirect.com/science/article/pii/S2352578922001205

Internet

http://www.sciencedirect.com/science/article/pii/S2352578922001205

Similar Items